Hornsby Ku-ring-gai Hospital is a hospital in Sydney, Australia, located on Palmerston Road in Hornsby. As a provider of care since 1933, the Hornsby Ku-ring-gai Hospital is a major metropolitan hospital, and is a teaching hospital of the University of Sydney.

There are 270 beds in Hornsby Ku-ring-gai Hospital.

During the past decade, Hornsby Ku-ring-gai Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hornsby Ku-ring-gai Hospital" #1 sponsor was "Pfizer" with 3 trials, followed by "DePuy Orthopaedics" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 1 trials sponsored and "Belinda Howe" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hornsby Ku-ring-gai Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Australasian College for Emergency Medicine" with 1 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Hunter Medical Research Institute" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hornsby Ku-ring-gai Hospital" are "Alzheimer Disease" (4 trials), "Alzheimer's Disease" (2 trials), "Osteoarthritis" (2 trials), "Critical Illness and Mechanical Ventilation" (1 trials) and "Hypovolemia" (1 trials). Many other conditions were trialed in "Hornsby Ku-ring-gai Hospital" in a lesser frequency.

Most popular intervention types in "Hornsby Ku-ring-gai Hospital" are "Drug" (8 trials), "Device" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bapineuzumab" (2 trials), "placebo" (2 trials), "0.9% sodium chloride" (1 trials) and "ATTUNE Primary Total Knee Arthroplasty" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hornsby Ku-ring-gai Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Hornsby Ku-ring-gai Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hornsby Ku-ring-gai Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hornsby Ku-ring-gai Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".